deltatrials
Terminated PHASE2 INTERVENTIONAL 3-arm NCT02997696

A Study to Evaluate ONO-4474 in Patients With Pain Due to Osteoarthritis of the Knee (MOTION)

A Randomised, Double-blind, Placebo Controlled, Parallel Group, Multi-centre, Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of ONO-4474 in Patients With Pain Due to Osteoarthritis of the Knee

Sponsor: Ono Pharmaceutical Co. Ltd

Conditions Osteoarthritis, Knee Pain
Interventions ONO-4474 Placebo matching ONO-4474
Updated 9 times since 2017 Last updated: Feb 23, 2018 Started: Jan 31, 2017 Primary completion: Jan 9, 2018 Completion: Jan 9, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The study was stopped for business reasons. No safety issues were reported.

Other terminated trials from Ono Pharmaceutical Co. Ltd

More terminations from Ono Pharmaceutical Co. Ltd

Other Osteoarthritis, Knee trials with similar outcome

Browse all Osteoarthritis, Knee trials

This PHASE2 trial investigates Osteoarthritis, Knee and Pain and is currently terminated or withdrawn. Ono Pharmaceutical Co. Ltd leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshotNot Yet Recruiting~May 2017 – ~Oct 2017 · 5 months · monthly snapshotRecruiting~Oct 2017 – ~Mar 2018 · 5 months · monthly snapshotRecruiting~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 10 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

▶ Show 4 earlier versions

  1. Mar 2018 — Jun 2018 [monthly]

    Terminated PHASE2

    Status: Recruiting → Terminated

  2. Oct 2017 — Mar 2018 [monthly]

    Recruiting PHASE2

  3. May 2017 — Oct 2017 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  4. Jan 2017 — May 2017 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ono Pharmaceutical Co. Ltd
Data source: Ono Pharmaceutical Co. Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

A Coruña, Spain , Aalborg, Denmark , Balatonfüred, Hungary , Barcelona, Spain , Barnsley, United Kingdom , Bialystok, Poland , Blackpool, United Kingdom , Budapest, Hungary , Eger, Hungary , Elblag, Poland and 29 more locations